symptomatic, aggressive, sporadic, unresectable, locally
Showing 1 - 1 of 1
Vandetanib in RET -/+ Metastatic Medullary Thyroid Cancer
Completed
- Symptomatic, Aggressive, Sporadic, Unresectable, Locally
- Advanced/Metastatic Medullary Thyroid Cancer (MTC)
- Vandetanib 300 mg
-
Belgium, Belgium
- +7 more
Oct 15, 2020